FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 74 filers reported holding FATE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,021 | -55.3% | 3,360 | 0.0% | 0.00% | -100.0% |
Q1 2024 | $24,662 | +96.3% | 3,360 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $12,566 | +76.4% | 3,360 | 0.0% | 0.00% | – |
Q3 2023 | $7,123 | -86.5% | 3,360 | -50.0% | 0.00% | -100.0% |
Q2 2023 | $52,652 | +43.6% | 6,720 | +100.0% | 0.00% | -50.0% |
Q1 2023 | $36,658 | +83213.6% | 3,360 | -14.1% | 0.00% | +100.0% |
Q4 2022 | $44 | -99.9% | 3,913 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $43,000 | 0.0% | 3,876 | +0.9% | 0.00% | 0.0% |
Q2 2022 | $43,000 | -14.0% | 3,842 | -14.8% | 0.00% | 0.0% |
Q1 2022 | $50,000 | – | 4,507 | – | 0.00% | – |
Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2021 | $12,000 | – | 150 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | -100.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 20 | -99.9% | 0.00% | -100.0% |
Q4 2018 | $302,000 | -25.8% | 24,958 | -0.1% | 0.02% | +11.8% |
Q3 2018 | $407,000 | -11.3% | 24,974 | -38.3% | 0.02% | -15.0% |
Q2 2018 | $459,000 | +678.0% | 40,500 | +321.9% | 0.02% | +566.7% |
Q1 2018 | $59,000 | 0.0% | 9,600 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $59,000 | +168.2% | 9,600 | +71.4% | 0.00% | +200.0% |
Q3 2017 | $22,000 | +29.4% | 5,600 | +9.8% | 0.00% | 0.0% |
Q2 2017 | $17,000 | -32.0% | 5,100 | -5.6% | 0.00% | 0.0% |
Q1 2017 | $25,000 | -16.7% | 5,400 | -55.1% | 0.00% | 0.0% |
Q4 2016 | $30,000 | +57.9% | 12,040 | +94.2% | 0.00% | 0.0% |
Q3 2016 | $19,000 | +111.1% | 6,200 | +19.2% | 0.00% | 0.0% |
Q2 2016 | $9,000 | -50.0% | 5,200 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $18,000 | – | 5,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |